Nuvation Bio Inc.
NUVBBiotechnology
$4.77+3.92%As of Oct 29vs prior close
- Market cap
- $1.7B
- P/E (TTM)
- –
- From 52W high
- −50.00%
- EPS (LTM)
- -$0.44
- Revenue (LTM)
- $169.9M
- Net margin
- -88.19%
- Dividend yield
- 0.00%
Nomior Score
48
Steady ProfileBottom 47% of the scored universe
Growth68
Quality47
Value52
Momentum48
Resilience35
Growth
$169.9Mrevenue, LTM
YE23 $0LTM $169.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 161% of revenue, narrower by 1155 pts on a year.
Who owns it
2funds, 4 tracked portfolios